0000930413-11-004271.txt : 20110606 0000930413-11-004271.hdr.sgml : 20110606 20110606204913 ACCESSION NUMBER: 0000930413-11-004271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110602 FILED AS OF DATE: 20110606 DATE AS OF CHANGE: 20110606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG DAVID C CENTRAL INDEX KEY: 0001251336 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 11896840 MAIL ADDRESS: STREET 1: C/O ENZO BIOCHEM INC STREET 2: 527 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 c65902_form4.xml X0303 4 2011-06-02 0 0000316253 ENZO BIOCHEM INC ENZ 0001251336 GOLDBERG DAVID C C/O ENZO BIOCHEM INC 527 MADISON AVE NEW YORK NY 10022 0 1 0 0 VP CorpDev Pres Enz Clin Labs Common Stock, par value $0.01 2011-06-02 4 A 0 10000 A 123934 D The Reporting Person was granted 10,000 shares of restricted common stock, par value $0.01 per share ("Common Stock"), of the Company on June 2, 2011 in connection with his service as an officer of the Company. The shares will vest in three equal annual installments, beginning on June 2, 2012. Includes (i) 979 shares of Common Stock indirectly beneficially owned through the UGMA accounts of Mr. Goldberg's children, and (ii) 9,227 shares of Common Stock held in the Company's 401(k) plan. /s/ David C. Goldberg 2011-06-06